NL1027109A1 - Connection and use with treatment. - Google Patents

Connection and use with treatment.

Info

Publication number
NL1027109A1
NL1027109A1 NL1027109A NL1027109A NL1027109A1 NL 1027109 A1 NL1027109 A1 NL 1027109A1 NL 1027109 A NL1027109 A NL 1027109A NL 1027109 A NL1027109 A NL 1027109A NL 1027109 A1 NL1027109 A1 NL 1027109A1
Authority
NL
Netherlands
Prior art keywords
treatment
connection
Prior art date
Application number
NL1027109A
Other languages
Dutch (nl)
Other versions
NL1027109C2 (en
Inventor
Luciano Adorini
Enrico Colli
Original Assignee
Bioxell Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0322395A external-priority patent/GB0322395D0/en
Priority claimed from GB0325598A external-priority patent/GB2407499B/en
Priority claimed from GB0416876A external-priority patent/GB0416876D0/en
Application filed by Bioxell Spa filed Critical Bioxell Spa
Publication of NL1027109A1 publication Critical patent/NL1027109A1/en
Application granted granted Critical
Publication of NL1027109C2 publication Critical patent/NL1027109C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NL1027109A 2003-09-24 2004-09-24 Connection and use with treatment. NL1027109C2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0322395A GB0322395D0 (en) 2003-09-24 2003-09-24 Methods for treating bladder dysfunction and related compounds and compositions
GB0322395 2003-09-24
GB0325598A GB2407499B (en) 2003-11-03 2003-11-03 Vitamin D3 analogue for use in the treatment of BPH
GB0325598 2003-11-03
GB0416876 2004-07-29
GB0416876A GB0416876D0 (en) 2004-07-29 2004-07-29 Compound and use in treatment

Publications (2)

Publication Number Publication Date
NL1027109A1 true NL1027109A1 (en) 2005-03-29
NL1027109C2 NL1027109C2 (en) 2005-05-03

Family

ID=34229055

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1027109A NL1027109C2 (en) 2003-09-24 2004-09-24 Connection and use with treatment.

Country Status (12)

Country Link
EP (1) EP1673096A1 (en)
JP (2) JP2007506699A (en)
CN (1) CN100488511C (en)
BE (1) BE1016292A3 (en)
BR (1) BRPI0404050A (en)
CH (1) CH698144B1 (en)
EA (1) EA010240B1 (en)
FR (1) FR2859910B1 (en)
HK (1) HK1085373A1 (en)
NL (1) NL1027109C2 (en)
NZ (1) NZ535531A (en)
WO (1) WO2005027923A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006038611A1 (en) * 2004-10-05 2008-05-15 キッセイ薬品工業株式会社 Preventive and / or therapeutic agent for urinary storage disorder associated with lower urinary tract obstruction disease
CA2582045C (en) * 2004-10-06 2013-10-22 Kissei Pharmaceutical Co., Ltd. Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
US20120164240A1 (en) 2010-12-22 2012-06-28 Audino David Lawrence Enriched a. blitoides compositions and uses thereof
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
FR3063906A1 (en) * 2017-03-20 2018-09-21 Pierre Fabre Medicament USE OF COPAIFERA OLEORESIN IN THE PATHOLOGIES OF THE PROSTATE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
TW403735B (en) * 1995-11-22 2000-09-01 Hoffmann La Roche 25-hydroxy-16-ene-26, 27-bishomo-cholecalciferol
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
WO1998051678A1 (en) * 1997-05-16 1998-11-19 Women & Infants Hospital CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US6255501B1 (en) * 1999-04-26 2001-07-03 Hoffman-La Roche Inc. Process for preparing antiosteoporotic agents
WO2003034961A1 (en) * 2001-10-23 2003-05-01 Euro-Celtique, S.A. Terazosin transdermal device and methods
WO2003047595A1 (en) * 2001-12-03 2003-06-12 Novacea, Inc. Pharmaceutical compositions comprising active vitamin d compounds

Also Published As

Publication number Publication date
NL1027109C2 (en) 2005-05-03
BE1016292A3 (en) 2006-07-04
HK1085373A1 (en) 2006-08-25
EA010240B1 (en) 2008-06-30
CH698144B1 (en) 2009-05-29
EA200401100A1 (en) 2005-04-28
CN1615891A (en) 2005-05-18
FR2859910A1 (en) 2005-03-25
EP1673096A1 (en) 2006-06-28
FR2859910B1 (en) 2006-04-28
NZ535531A (en) 2006-03-31
CN100488511C (en) 2009-05-20
WO2005027923A1 (en) 2005-03-31
JP2007506699A (en) 2007-03-22
BRPI0404050A (en) 2005-06-14
JP2009035559A (en) 2009-02-19

Similar Documents

Publication Publication Date Title
NL1025404A1 (en) Pyrazolo-triazine compounds and use thereof.
DE60327864D1 (en) BALLOONDECKER WITH CANNULA
IS8026A (en) Antibodies against amyloids, combinations, methods and uses
NL1027833A1 (en) Compounds useful in therapy.
NO20053974D0 (en) Tienopyrimidine Compounds and Their Use.
NL1024643A1 (en) Purine compounds and their use.
DE602004028934D1 (en) BENZOE4,5THTHIENOE2,3-DIPYRIMIDIN-4-ONE AND ITS THERAPEUTIC USE
NO20053947D0 (en) Improved antitumoral treatments.
ATE472576T1 (en) POLYALKENAMINES WITH IMPROVED USE PROPERTIES
ITMI20031145A1 (en) DEVICE AND COOKING PROCEDURE.
HK1071784A1 (en) Impeller and sewage treatment pump including the same
DE602005020457D1 (en) MASTER-SLAVE-FLIP-FLOP, TRIGGER-FLIP-FLOP AND COUNTER
ATE460415T1 (en) THERAPEUTIC PYRAZOLOA3,4-BUPYRIDINES AND INDAZOLES
GB0303663D0 (en) Assays and medical treatments
NL1027109A1 (en) Connection and use with treatment.
NO20053189D0 (en) HVC-combination therapy.
NO20053898D0 (en) Use and proceeding at footballshoes
EP1660088A4 (en) Pyridomorphinans, pyridazinomorphinans and use thereof
IS8391A (en) Use of siramine in the treatment of cancer
ES1055129Y (en) DRYER-GRINDER OF COVERS AND SIMILAR.
ES1055586Y (en) POWER DEVICE WITH HANDBAG AND HANDBAG.
NO20022747D0 (en) treatment chair
ES1055675Y (en) PERFECTED SYRINGE.
ES1051272Y (en) MULTIPLICABLE PEOPLE.
ES1055108Y (en) ANTIESGUINCES ANKLE AND SPINILLERA.

Legal Events

Date Code Title Description
AD1B A search report has been drawn up
PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20110401